Author

Beth Brunton

Observed name: BA Brunton

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5036668231

An unusual presentation of emphysematous cystitis

1998 · John Weddle, Beth Brunton, et al. · The American Journal of Emergency Medicine · 22

Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.

2021 · Joselle Cook, Kah Whye Peng, et al. · Journal of Clinical Oncology · 7

Abstract P6-21-03: Phase I trial of intratumoral (IT) administration of a NIS-expressing derivative manufactured from a genetically engineered strain of measles virus (MV)

2019 · MC Liu, K-W Peng, et al. · Cancer Research · 6

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta, in Patients with Relapsed or Refractory Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), and T-Cell Neoplasms (TCL)

2020 · Joselle Cook, Kah-Whye Peng, et al. · Blood · 4

TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies

2021 · Joselle Cook, Kah-Whye Peng, et al. · Clinical Lymphoma Myeloma & Leukemia · 2

Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies

2021 · Joselle Cook, Kah-Whye Peng, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 6

Citation count: 41

H-index: 4

I10-index: 1